4DMedical Limited (ASX:4DX)

Australia flag Australia · Delayed Price · Currency is AUD
1.545
+0.235 (17.94%)
Sep 5, 2025, 4:19 PM AEST
17.94%
Market Cap724.40M
Revenue (ttm)5.85M
Net Income (ttm)-30.07M
Shares Out468.87M
EPS (ttm)-0.14
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume31,045,223
Average Volume7,810,386
Open1.400
Previous Close1.310
Day's Range1.350 - 1.760
52-Week Range0.225 - 1.760
Beta1.71
RSI90.82
Earnings DateAug 29, 2025

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functiona... [Read more]

Sector Healthcare
Founded 2012
Employees 145
Stock Exchange Australian Securities Exchange
Ticker Symbol 4DX
Full Company Profile

Financial Performance

In 2025, 4DMedical's revenue was 5.85 million, an increase of 55.91% compared to the previous year's 3.75 million. Losses were -30.07 million, -16.42% less than in 2024.

Financial Statements

News

There is no news available yet.